The combination of DIM and paclitaxel highly downregulates the Akt/FOXM1 signaling cascade in gastric cancer cells: FoxM1 and its effector genes, CDK4, p53, and cyclin D1, are also more significantly decreased by combined treatment than by treatment with one compound [53]. The gene discussed is AKT1; the disease is gastric cancer.